Back to Clinical Trials Overview
Back To Cancer Clinical Trials
A Phase III trial of Pelvic Radiation therapy vaginal cuff brachytherapy followed by paclitaxel/carboplatin in patients with high risk, early stage endometrial cancer (endometrium; uterus)
Principal Investigator(s): Konstantin Zakashansky
A Phase 3, Randomized, Double-Blind Trial of Weekly Paclitaxel Plus AMG 386 or Placebo in Women With Recurrent Partially Platinum Sensitive or Resistant Epithelial Ovarian, Primary Peritoneal or Fallopian Tube Cancers
Principal Investigator(s): Konstantin Zakashansky
A Randomized Phase III Trial of Cisplatin and Tumor Volume Directed Irradiation Followed by Carboplatin and Paclitaxel vs. Carboplatin and Paclitaxel for Optimally Debulked, Advanced Endometrial Carcinoma (endometrium; uterus)
Principal Investigator(s): Linus Chuang
A Phase 3, Randomized, Double-Blind Trial of Pegylated Liposomal Doxorubicin (PLD) Plus AMG 386 or Placebo in Women with Recurrent Partially Platinum Sensitive or Resistant Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Principal Investigator(s): Konstantin Zakashansky
Back To Cancer Clinical Trials
Your search for "Other Female Genital" returned 4 results:
A Phase III trial of Pelvic Radiation therapy vaginal cuff brachytherapy followed by paclitaxel/carboplatin in patients with high risk, early stage endometrial cancer (endometrium; uterus)
Principal Investigator(s): Konstantin Zakashansky
A Phase 3, Randomized, Double-Blind Trial of Weekly Paclitaxel Plus AMG 386 or Placebo in Women With Recurrent Partially Platinum Sensitive or Resistant Epithelial Ovarian, Primary Peritoneal or Fallopian Tube Cancers
Principal Investigator(s): Konstantin Zakashansky
A Randomized Phase III Trial of Cisplatin and Tumor Volume Directed Irradiation Followed by Carboplatin and Paclitaxel vs. Carboplatin and Paclitaxel for Optimally Debulked, Advanced Endometrial Carcinoma (endometrium; uterus)
Principal Investigator(s): Linus Chuang
A Phase 3, Randomized, Double-Blind Trial of Pegylated Liposomal Doxorubicin (PLD) Plus AMG 386 or Placebo in Women with Recurrent Partially Platinum Sensitive or Resistant Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Principal Investigator(s): Konstantin Zakashansky
Contact Us
Office of Research Services (ORS)
Tel: 212-824-7294
Send e-mail
Related Resources
For Patients
- Find a Mount Sinai Doctor
- Find a Mount Sinai Department or Institute
- Research Match
- Clinicaltrials.gov
- National Cancer Clinical Trials
- Video - Participating in Research - You Can Be Part of the Answer
- The Center for Information & Study on Clinical Research Participation
- Patients Like Me
For Investigators
- Office of Research Services (ORS)
- How to Post Research Projects on the Website
- Conduits
- Research Information Technology
- Communicating with Research Subjects